Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 231.00
Bid: 224.00
Ask: 238.00
Change: 1.00 (0.43%)
Spread: 14.00 (6.25%)
Open: 230.00
High: 232.00
Low: 230.00
Prev. Close: 230.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

12 Sep 2022 07:05

RNS Number : 0182Z
Spectra Systems Corporation
12 September 2022
 

Spectra Systems Corporation

("The Company" or "Spectra Systems")

Appointment of Non-Executive Director

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software is delighted to announce that it has agreed to appoint Dr. Barbara Paldus (aged 52) as an Independent Non-Executive Director.

Barbara has over 20 years of industry expertise in developing emerging domestic and international marketplaces, including bio-processing, personalized medicine, cell therapy, biotech beauty, and analytical process equipment. She founded two companies whose combined revenue exceeded $250M in 2021. She also has a doctorate in electrical and electronics engineering from Stanford University.

In 1998 Barbara was a founder of Picarro, a leading provider of cavity-ring-down instruments (CRDS) and solutions to measure greenhouse gas (GHG) concentrations, trace gases, and stable isotopes across many scientific applications, along with the energy, life science, and utilities markets where she successfully exited in 2006. In 2005 she founded Finess Solutions, a leader in the development of scalable control automation systems and software for bioproduction. Its proprietary Smart technology, which consists of sensors, controllers, and software is designed to optimize the bioproduction workflow. Finess Solutions was sold to Thermo Fisher in 2017. Barbara was also an operating partner for Skymoon Ventures from 2005 until 2017, a venture fund ($100 million invested) focused on early-stage chip, GPS, bioproduction, optical laser components, and analytical instrumentation.

Barbara is currently the CEO and Founder of Codex Labs, a Global collection of biotech-based skincare solutions based on disruptive plant-based biotech ingredients, cGMP manufacturing, industry-leading carbon-footprint minimizing packaging, and data-driven clinical testing.

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Barbara to Spectra Systems and believe that her extensive entrepreneurial experience, particularly in technology solutions will be of immense value to us."

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

Barbara Alice Paldus' directorships and partnerships in the last five years are as follows:

 

Current Directorships

Codex Beauty Corporation

Codex Beauty Corporation

Sekhmet Ventures LLC

Codex Beauty (UK) Ltd

Codex Labs Europe Ltd

Adva Biotechnology Ltd

Past Directorships

Codex Beauty Service Corporation

Finesse Solutions Inc

Sekhmet Ltd

There is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

WH Ireland Limited (Nominated Adviser and Broker)

Chris Fielding (Head of Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

 

Tel: +44 (0)20 3328 5665

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKDBPABKDOCD
Date   Source Headline
1st Sep 20157:03 amRNSInterim results for 6 months ended 30 June 2015
14th Aug 20152:42 pmRNSRemoval of Restrictions from Common Stock
14th Aug 20157:00 amRNSModified Covert Materials Supply Contract
3rd Jul 20157:00 amRNSHolding(s) in Company
2nd Jul 20157:00 amRNSContract Win
19th Jun 201511:17 amRNSPosting of Annual Report and Accounts
16th Jun 20154:06 pmRNSRemoval of Restrictions from Common Stock
19th May 20158:46 amRNSRemoval of Restrictions from Common Stock
18th May 20153:50 pmRNSHolding(s) in Company
22nd Apr 20157:31 amRNSPreliminary Results
2nd Apr 20153:05 pmRNSRemoval of Restrictions from Common Stock
19th Mar 20152:23 pmRNSRemoval of Restrictions from Common Stock
5th Mar 20158:40 amRNSHolding(s) in Company
10th Feb 20157:00 amRNSContract Win
3rd Feb 20158:02 amRNSHolding(s) in Company
23rd Dec 20144:35 pmRNSHolding(s) in Company
9th Dec 20147:00 amRNSNotice of Allowance from the US Patent Office
4th Nov 20145:51 pmRNSHolding(s) in Company
20th Oct 20147:00 amRNSAGM Postponement
17th Oct 20147:19 amRNSUpdate on Aeris Banknote Cleaning Testing Program
30th Sep 20147:00 amRNSInterim results
10th Sep 20149:42 amRNSTR-1: Notification of major interest in shares
1st Sep 20147:00 amRNSNotice of AGM
24th Jul 20147:00 amRNSPartnership with Cool Clean Technologies
22nd Jul 20147:00 amRNSContract wins
24th Jun 20148:15 amRNSPosting of Annual Report and Accounts
23rd Jun 20147:00 amRNSCentral Bank testing Spectra's Aeris technology
20th Jun 20147:00 amRNSSettlement of lawsuit and termination of agreement
12th Jun 20147:00 amRNSTesting of Soiled Banknote Technology
9th May 20147:00 amRNSTR-1: Notification of major interest in shares
30th Apr 20147:00 amRNSPreliminary Results
29th Apr 20147:00 amRNSSpectra Systems Provides ICS Services in Michigan
16th Apr 20143:46 pmRNSTR-1: Notification of major interest in shares
25th Mar 20147:01 amRNSTR-1: Notification of major interest in shares
3rd Mar 20147:00 amRNSCompletion of Acquisition of Inksure Technologies
4th Feb 20143:33 pmRNSTR-1: Notification of major interest in shares
30th Jan 20147:00 amRNSTrading Update
16th Jan 20147:00 amRNSFirst Commercial Orders for Manufacturing Facility
13th Jan 20147:00 amRNSExtension of InkSure Asset Purchase Agreement
13th Jan 20147:00 amRNSSecond G8 Central Bank Test Program
25th Nov 20137:00 amRNSAgreement to test Banknote Cleaning Technology
19th Nov 20137:00 amRNSJudgment Reducing Potential Lawsuit Exposure
14th Nov 20137:00 amRNSApproval to deliver suite of sensors worth $8m
27th Sep 20137:00 amRNSInterim Results
27th Aug 20137:00 amRNSNotice of AGM
2nd Apr 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSRemoval of Restrictions from Common Stock
18th Feb 20137:00 amRNSPre-Close Trading Update
18th Dec 20127:00 amRNSRemoval of Restrictions From Common Stock
17th Dec 20127:00 amRNSAGM Postponement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.